| Literature DB >> 33553469 |
Cheryl Volling1, Narges Ahangari1, Jessica J Bartoszko2, Brenda L Coleman1, Felipe Garcia-Jeldes3, Alainna J Jamal1, Jennie Johnstone1, Christopher Kandel1, Philipp Kohler4, Helena C Maltezou5, Lorraine Maze Dit Mieusement6, Nneka McKenzie1, Dominik Mertz7, Adam Monod1, Salman Saeed8, Barbara Shea1, Rhonda L Stuart9, Sera Thomas1, Elizabeth Uleryk10, Allison McGeer1.
Abstract
Increasing rates of antimicrobial-resistant organisms have focused attention on sink drainage systems as reservoirs for hospital-acquired Gammaproteobacteria colonization and infection. We aimed to assess the quality of evidence for transmission from this reservoir. We searched 8 databases and identified 52 studies implicating sink drainage systems in acute care hospitals as a reservoir for Gammaproteobacterial colonization/infection. We used a causality tool to summarize the quality of evidence. Included studies provided evidence of co-occurrence of contaminated sink drainage systems and colonization/infection, temporal sequencing compatible with sink drainage reservoirs, some steps in potential causal pathways, and relatedness between bacteria from sink drainage systems and patients. Some studies provided convincing evidence of reduced risk of organism acquisition following interventions. No single study provided convincing evidence across all causality domains, and the attributable fraction of infections related to sink drainage systems remains unknown. These results may help to guide conduct and reporting in future studies.Entities:
Keywords: Gammaproteobacteria; gram-negative bacteria; infection control; sink drains; waste water
Year: 2020 PMID: 33553469 PMCID: PMC7856333 DOI: 10.1093/ofid/ofaa590
Source DB: PubMed Journal: Open Forum Infect Dis ISSN: 2328-8957 Impact factor: 3.835
Figure 1.Flow diagram results of literature search.
Characteristics of Included Studies (n = 52)
| Author, Country | Study Dates | Hospital Unit(s) | Population Characteristics | Bacteria | Typing Methodsa |
|---|---|---|---|---|---|
| Cabrera [ | 1959–1960 | Ward | Neonatal |
| Biotyping, serotyping |
| Kohn [ | 1963–1964 | Ward | Medical-surgical, burn |
| Serotyping, pyocin typing |
| Thomas [ | 1970 | OR | Surgical |
| Serotyping, phage typing |
| Teres [ | 1970–1972 | ICU | Medical-surgical |
| Pyocin typing |
| Edmonds [ | 1971-1971 | ICU | Medical-surgical, burn |
| Serotyping, pyocin typing, phage typing |
| Riser [ | 1971–1976 | Ward | Medical-surgical |
| Serotyping |
| Breitfellner [ | 1973–1974 | Ward | Neonatal, obstetric |
| Antibiotic susceptibility, serotyping |
| Brown [ | NS (pre-1977) | ICU | Neonatal |
| Pyocin typing |
| Cooke [ | NS (pre-1979) | Ward | Medical-surgical, neonatal |
| Serotyping |
| Gunther [ | NS (pre-1980) | Ward | Medical, pediatric |
| Pyocin typing |
| Levin [ | NS (pre-1984) | ICU | Medical-surgical |
| Serotyping |
| Döring [ | 1988–1989 | ICU | Medical-surgical |
| Exotoxin A probing |
| Döring [ | 1989–1989 | Ward | Medical, pediatric, immunocompromised |
| Exotoxin A probing |
| Döring [ | 1992–1992 | Ward | Medical |
| PFGE |
| Kerr [ | 1993-1993 | ICU | Medical |
| RAPD PCR |
| Bert [ | 1995–1997 | ICU | Surgical |
| PFGE |
| Berthelot [ | 1995–1996 | ICU | Medical-surgical, mechanically ventilated |
| PFGE |
| Pitten [ | 1997–1998 | ICU, ward | Medical-surgical |
| PFGE |
| Gillespie [ | 1997–1998 | Ward | Medical, immunocompromised |
| PFGE |
| Lowe [ | 1997–2011 | ICU, ward | Medical-surgical |
| PFGE |
| Orrett [ | 1998–1998 | ICU | Surgical, neonatal |
| Antibiotic susceptibility |
| Ahmad [ | 1998–2002 | ICU, ward | Medical, pediatric |
| Antibiotic susceptibility |
| Sissoko [ | 2002–2004 | ICU | Medical | Gram-negative bacteria | Typing not reported |
| Hota [ | 2004–2006 | ICU | Medical-surgical, immunocompromised |
| PFGE |
| La Forgia [ | 2004–2008 | ICU | Medical-surgical |
| Restriction endonuclease of genomic DNA |
| Johansson [ | 2004–2009 | ICU, ward | Medical-surgical, immunocompromised |
| PFGE, MLVA |
| Schneider [ | 2004–2010 | Ward | Medical, pediatric, immunocompromised |
| RAPD PCR |
| Cholley [ | 2006–2006 | ICU | Medical-surgical |
| PFGE |
| Longtin [ | 2006–2008 | ICU | Medical-surgical |
| PFGE |
| Inglis [ | 2006–2008 | ICU, ward | Medical-surgical |
| PFGE |
| Tofteland [ | 2007–2010 | ICU | Medical-surgical |
| PFGE |
| Maltezou [ | 2007–2010 | ICU | Neonatal |
| PFGE |
| Salimi [ | 2008–2008 | ICU | Medical-surgical, burn |
| PFGE |
| Landelle [ | 2008–2009 | ICU, ward | Medical-surgical |
| PFGE |
| Stjarne Aspelund [ | 2008–2015 | Ward | Medical |
| PFGE |
| Ling [ | 2009–2009 | Ward | Medical, immunocompromised |
| PFGE |
| Vergara Lopez [ | 2009–2011 | ICU | Medical-surgical |
| PFGE |
| Kotsanas [ | 2009–2012 | ICU | Medical-surgical |
| PFGE |
| Willmann [ | 2009–2013 | ICU, ward | Medical, immunocompromised |
| WGS |
| Starlander [ | 2010 | ICU | Surgical |
| PFGE |
| Zhou [ | 2011–2011 | ICU | Surgical |
| PFGE |
| Amoureux [ | 2011–2012 | ICU, ward | Medical-surgical, pediatric |
| PFGE |
| Wolf [ | 2011–2012 | ICU | NS | ESBL-producing gram-negative bacilli | AFLP |
| Lowe [ | 2011–2012 | Ward | Medical-surgical |
| PFGE |
| Chapuis [ | 2011–2013 | Ward | Medical, immunocompromised |
| PFGE |
| Leitner [ | 2011–2013 | Ward | Medical |
| MLST, rep-PCR |
| Fusch [ | 2011–2013 | ICU | Neonatal |
| Typing not reported |
| Wendel [ | 2011–2014 | ICU, ward | Medical-surgical |
| PFGE |
| Clarivet [ | 2012–2014 | ICU | Medical-surgical |
| PFGE, rep-PCR |
| Pantel [ | 2012–2014 | ICU, OR | NS |
| MLST, rep-PCR |
| Seara [ | 2013–2014 | NS | Medical-surgical |
| PFGE |
| Davis [ | 2013–2014 | ICU | Neonatal |
| WGS |
Abbreviations: ESBL, extended-spectrum beta lactamase; ICU, intensive care unit; NS, not specified; OR, operating room.
aTyping method examples and their relative discriminatory power based on consensus evaluation by microbiologists and infection control practitioners: Adequately discriminatory: PFGE, pulsed field gel electrophoresis; RAPD PCR, random amplified polymorphic DNA polymerase chain reaction; RFLP, restriction fragment length polymorphism; WGS, whole-genome sequencing. Less discriminatory: AFLP, amplified fragment length polymorphism; ERIC PCR, enterobacterial repetitive intergenic consensus polymerase chain reaction; MLEE, multilocus enzyme electrophoresis; MLST, multilocus sequence typing; MLVA, multiple locus variable number tandem repeat analysis; rep-PCR, repetitive element palindromic polymerase chain reaction; VNTR, variable number tandem repeat. Inadequate: phage typing, biotyping, antibiotic susceptibility pattern, pyocin typing.
Summary Table of Scores for 2 Raters Applying the Modified CADDIS to 52 Articles Included in a Systematic Review
| Study | Spatial/Temporal Co-occurrence | Temporal Sequence | Stressor–Response Relationship | Causal Pathwaya | Evidence of Exposure and Biological Specificityb | Manipulation of Exposure |
|---|---|---|---|---|---|---|
| Hota [ | + | 0 | 0 | + | ++ | +++ |
| Bert [ | + | 0 | 0 | + | ++ | +++ |
| Schneider [ | + | 0 | 0 | 0 | ++ | +++ |
| Stjarne Aspelund [ | + | 0 | 0 | 0 | ++ | +++ |
| Tofteland [ | + | 0 | 0 | 0 | ++ | +++ |
| Vergara Lopez [ | + | 0 | 0 | 0 | ++ | +++ |
| Wolf [ | + | ++ | 0 | 0 | 0 | +++ |
| Sissoko [ | + | 0 | 0 | + | 0 | +++ |
| Cabrera [ | + | ++ | 0 | + | 0 | +++ |
| Chapuis [ | + | ++ | 0 | 0 | ++ | + |
| Clarivet [ | + | ++ | 0 | 0 | ++ | + |
| Longtin [ | + | ++ | 0 | 0 | ++ | + |
| Lowe [ | + | ++ | 0 | 0 | ++ | + |
| Lowe [ | + | ++ | 0 | 0 | ++ | + |
| Davis [ | + | 0 | 0 | + | ++ | + |
| Landelle [ | + | 0 | 0 | + | ++ | + |
| Starlander [ | + | 0 | 0 | + | ++ | + |
| Wendel [ | + | 0 | 0 | + | ++ | + |
| Gillespie [ | + | 0 | 0 | 0 | ++ | + |
| Johansson [ | + | 0 | 0 | 0 | ++ | + |
| La Forgia [ | + | 0 | 0 | 0 | ++ | + |
| Ling [ | + | 0 | 0 | 0 | ++ | + |
| Maltezou [ | + | 0 | 0 | 0 | ++ | + |
| Pitten [ | + | 0 | 0 | 0 | ++ | + |
| Seara [ | + | 0 | 0 | 0 | ++ | + |
| Willmann [ | + | 0 | 0 | 0 | ++ | + |
| Leitner [ | + | 0 | 0 | 0 | + | + |
| Pantel [ | + | 0 | 0 | 0 | + | + |
| Riser [ | + | 0 | 0 | + | 0 | + |
| Thomas [ | + | 0 | 0 | + | 0 | + |
| Ahmad [ | + | 0 | 0 | 0 | 0 | + |
| Breitfellner [ | + | 0 | 0 | 0 | 0 | + |
| Fusch [ | + | 0 | 0 | + | 0 | + |
| Orrett [ | + | 0 | 0 | 0 | 0 | + |
| Döring [ | + | ++ | 0 | + | ++ | 0 |
| Berthelot [ | + | ++ | 0 | 0 | ++ | + |
| Zhou [ | + | ++ | 0 | 0 | ++ | 0 |
| Cholley [ | + | ++ | 0 | 0 | ++ | 0 |
| Amoureux [ | + | 0 | 0 | 0 | ++ | 0 |
| Inglis [ | + | 0 | 0 | 0 | ++ | 0 |
| Kerr [ | + | 0 | 0 | 0 | ++ | 0 |
| Kotsanas [ | + | 0 | 0 | 0 | ++ | 0 |
| Salimi [ | + | 0 | 0 | 0 | ++ | 0 |
| Döring [ | + | ++ | 0 | + | + | 0 |
| Brown [ | + | ++ | 0 | + | 0 | 0 |
| Cooke [ | + | ++ | 0 | + | 0 | 0 |
| Döring [ | + | ++ | 0 | + | + | 0 |
| Teres [ | + | ++ | 0 | + | 0 | 0 |
| Edmonds [ | + | ++ | 0 | 0 | 0 | 0 |
| Gunther [ | + | ++ | 0 | 0 | 0 | 0 |
| Levin [ | + | ++ | 0 | 0 | 0 | 0 |
| Kohn [ | + | ++ | 0 | 0 | 0 | 0 |
*The original Causal Analysis/Diagnosis Decision Information System (CADDIS) Summary Table of Scores can be found at https://www.epa.gov/caddis-vol1/summary-tables-scores[31].
+++ convincingly supports, ++ strongly supports, + somewhat supports, 0 neither supports nor weakens, - somewhat weakens, -- strongly weakens, --- convincingly weakens, or (R)/refutes causality.
aCausal pathway example: bacterial transmission from sinks splashing onto health care workers’ hands, and then to patients. See Döring et al. [44].
bEvidence of Exposure and Biological Specificity is based on adequacy of typing methods employed (Supplementary Table 1).
Hypothetical Causal Pathways Between Sink Drainage and Patient or Health Care Worker Colonization or Infection
| Hypothetical Causal Pathways | Number of Studies That Mention This Causal Pathway (References) | Number of Studies That Demonstrate 1 or More Potential Steps in This Causal Pathway (References) |
|---|---|---|
| Direct patient use of sinks with contaminated drains | 6 [ | |
| Water from sinks with contaminated drains used in relation to patient care activity | 1 [ | 1 [ |
| Contamination of health care personnel hands or gowns during use of sinks with contaminated drains, and subsequent transmission to patients | 24 [ | 5 [ |
| Splash or aerosolization of bacteria from contaminated sink drains into taps | 1 [ | 1 [ |
| Splash, aerosolization, or leak of bacteria from contaminated sink drains onto surroundings/fomites | 19 [ | 11 [ |
| Splash or aerosolization of bacteria from contaminated sink drains directly onto patients | 3 [ |
Manipulationsa of Exposure to Sink Drainage Systems in Effort to Reduce Patient or Health Care Worker Colonization or Infection
| Intervention Type | No. of Studies | No. (%) of Studies With Elimination or Reduction in Organism Acquisition | Proportion (%) of Successful Studies Reporting Co-intervention(s) | Durabilityb of Success in Studies Reporting Elimination or Reduction in Organism Acquisition, Duration, No. (%) of Studies | No. (%) of Studies With Reduction in Sink Drain Contamination but no Data on Impact on Organism Acquisition Before Other Interventions | No. (%) of Studies Reporting Unsuccessful Attempts to Reduce Sink Drain Contamination or Organism Acquisition |
|---|---|---|---|---|---|---|
| Additional sink cleaningc | 17 | 8 (47)d | 6 (75) | >6 mo: 4 (50%) | 3 (18)e | 5 (29)f |
| Repair or replacement of all or part of sink drainage | 10 | 8 (80) | 7 (88) | <6 mo: 1 (13%) | 2 (20) | |
| Installation of heater–vibrator trap devices | 6 | 4 (67) | 1 (25) | >6 mo: 3 (75%) | 2 (33) | |
| Replacement, cleaning, or disinfection of taps thought contaminated from drain | 1 | 1 (100) | 1 (100) | >6 mo: 1 (100%) | ||
| Sink removal, relocation, or closure of unit not otherwise detailed | 3 | 3 (100) | 2 (67) | >6 mo: 1 (33%) | ||
| Additional sink cleaning, repair, or replacement of all or part of sink drainage | 8 | 8 (100) | 5 (63) | <6 mo: 1 (13%) | ||
| Installation of heater–vibrator trap devices, taps redirected away from drain | 1 | 1 (100) | 0 | >6 mo: 1 (100%) | ||
| Replacement of traps, distance and barrier between drain | 1 | 1 (100) | 0 | >6 mo: 1 (100%) | ||
| Exchange and disinfection of traps, use of sink for patient care or placement of materials adjacent to sink forbidden, use of reusable hair wash basins stopped | 1 | 1 (100) | 1 (100) | >6 mo: 1 (100%) |
aAdditional details and references provided in Supplementary Table 3.
bDurability of successful reduction in organism acquisition by patients or health care workers determined based on reported periods with significantly reduced or no new cases of colonization or infection attributed to sinks, or time to manuscript submission/receipt in those who had reported sustained effect.
cUnclear effect of manipulation of exposure for 1 study with additional cleaning (disinfectant poured down drains).
dAdditional sink drain cleaning that was reported to result in some success without structural sink intervention included the use of chlorine or bleach products (n = 4), formalin (n = 1), or acetic acid (n = 1) with or without dismantling and physical cleaning, sink disinfection or cleaning not further specified (n = 2).
eAdditional sink drain cleaning that without structural sink intervention was reported to result in some reduction in drain contamination but not patient acquisition: accelerated H2O2 gel poured into drains and weekly cleaning with a sodium hypochlorite solution (n = 1), use of phenolics or paracetic acid (n = 1), use of bleach or chlorine and sodium hydroxide and alkyldimethyl amine oxide with steam cleaning (n = 1).
fAdditional sink drain cleaning that without structural sink intervention was reported unsuccessful included the use of bleach products with mechanical brushing (n = 1) or with phenolic flushing (n = 1), or with steam cleaning (n = 1), or the use of hydrogen peroxide (n = 1), or sink cleaning not further specified (n = 1).